Skip to content
You are now leaving https://www.ionispharma.com to visit

Biogen and Ionis Enter into New Collaboration to Identify Novel Therapies for the Treatment of Spinal Muscular Atrophy

CAMBRIDGE, Mass. & CARLSBAD, Calif. –(BUSINESS WIRE)–Dec. 19, 2017– Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that they have entered into a new collaboration agreement to identify new antisense oligonucleotide drug candidates for the treatment of spinal